Lexicon Pharmaceuticals, Inc. (LXRX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 12:14PM EDT. Market open.
| Previous close | 1.7700 |
| Open | 1.7800 |
| Bid | 1.7700 x 100 |
| Ask | 1.8000 x 100 |
| Day's range | 1.7550 - 1.8200 |
| 52-week range | 0.9200 - 3.7300 |
| Volume | |
| Avg. volume | 4,569,537 |
| Market cap | 439.533M |
| Beta (5Y monthly) | 1.27 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q1 2024 Earnings Call Transcript May 5, 2024 Lexicon Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone, and welcome to the Lexicon Pharmaceuticals First Quarter 2024 Financial Results Conference Call. At […]
- Thomson Reuters StreetEvents
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
Q1 2024 Lexicon Pharmaceuticals Inc Earnings Call
- GuruFocus.com
Lexicon Pharmaceuticals Inc (LXRX) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
Despite a net loss, Lexicon Pharmaceuticals Inc (LXRX) shows promising advancements in drug development and strategic financial maneuvers.
© 2024 Yahoo. All rights reserved.